Form 4: Marimed CEO Reports Stock Transaction
Insider Transaction (Form 4)
Jon R Levine, President and CEO, a Director and 10% owner of Marimed Inc., reported multiple transactions in common stock on October 15, 2026.
Summary
- Option exercise/conversion: acquired 30,625 Common stock on October 15, 2026; holds 21,396,782 after (Direct).
- Tax/exercise-price withholding: disposed of 8,989 Common stock at $0.06 ($539) on October 15, 2026; holds 21,387,793 after (Direct).
- Option exercise/conversion: disposed of 30,625 Restricted Stock Units (RSU) on October 15, 2026; holds 61,250 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jon R Levine — Director, Officer (President and CEO), 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-15 | Option exercise/conversion | Common stock | 30,625 | — | — | 21,396,782 |
| 2026-10-15 | Tax/exercise-price withholding | Common stock | 8,989 | $0 | $539 | 21,387,793 |
| 2026-10-15 | Option exercise/conversion | Restricted Stock Units (RSU) | 30,625 | — | — | 61,250 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-15 | Option exercise/conversion (30,625 shares) |
| 2026-10-15 | Tax/exercise-price withholding (8,989 shares) |
| 2026-10-15 | Option exercise/conversion (30,625 shares) |
Keywords
insider transaction, Form 4, MRMD, MARIMED INC., neutral, Jon R Levine
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.